Alpha Tau Medical Ltd has a consensus price target of $13.6, established from looking at the 17 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., Piper Sandler, and Citigroup on March 12, 2024, March 8, 2024, and December 15, 2023. With an average price target of $8 between HC Wainwright & Co., Piper Sandler, and Citigroup, there's an implied 220.00% upside for Alpha Tau Medical Ltd from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
03/12/2024 | DRTS | Buy Now | Alpha Tau Medical | $2.50 | 260% | HC Wainwright & Co. | Yi Chen | → $9 | Reiterates | Buy → Buy | Get Alert |
03/08/2024 | DRTS | Buy Now | Alpha Tau Medical | $2.50 | 180% | Piper Sandler | Jason Bednar | $8 → $7 | Reiterates | Overweight → Overweight | Get Alert |
12/15/2023 | DRTS | Buy Now | Alpha Tau Medical | $2.50 | 220% | Citigroup | Ashiq Mubarack | → $8 | Initiates | → Buy | Get Alert |
11/20/2023 | DRTS | Buy Now | Alpha Tau Medical | $2.50 | 260% | HC Wainwright & Co. | Yi Chen | → $9 | Reiterates | Buy → Buy | Get Alert |
11/17/2023 | DRTS | Buy Now | Alpha Tau Medical | $2.50 | 220% | Piper Sandler | Jason Bednar | $12 → $8 | Maintains | Overweight | Get Alert |
09/20/2023 | DRTS | Buy Now | Alpha Tau Medical | $2.50 | 260% | HC Wainwright & Co. | Yi Chen | → $9 | Reiterates | Buy → Buy | Get Alert |
08/29/2023 | DRTS | Buy Now | Alpha Tau Medical | $2.50 | 260% | HC Wainwright & Co. | Yi Chen | → $9 | Reiterates | Buy → Buy | Get Alert |
08/29/2023 | DRTS | Buy Now | Alpha Tau Medical | $2.50 | 820% | Cantor Fitzgerald | Kristen Kluska | → $23 | Reiterates | Overweight → Overweight | Get Alert |
08/18/2023 | DRTS | Buy Now | Alpha Tau Medical | $2.50 | 260% | HC Wainwright & Co. | Yi Chen | → $9 | Reiterates | Buy → Buy | Get Alert |
05/24/2023 | DRTS | Buy Now | Alpha Tau Medical | $2.50 | 260% | HC Wainwright & Co. | Yi Chen | → $9 | Reiterates | Buy → Buy | Get Alert |
05/18/2023 | DRTS | Buy Now | Alpha Tau Medical | $2.50 | 260% | HC Wainwright & Co. | Yi Chen | → $9 | Reiterates | Buy → Buy | Get Alert |
05/15/2023 | DRTS | Buy Now | Alpha Tau Medical | $2.50 | 260% | HC Wainwright & Co. | Yi Chen | → $9 | Reiterates | Buy → Buy | Get Alert |
04/24/2023 | DRTS | Buy Now | Alpha Tau Medical | $2.50 | 260% | HC Wainwright & Co. | Yi Chen | → $9 | Initiates | → Buy | Get Alert |
11/23/2022 | DRTS | Buy Now | Alpha Tau Medical | $2.50 | 380% | Piper Sandler | Jason Bednar | $19 → $12 | Maintains | Overweight | Get Alert |
04/14/2022 | DRTS | Buy Now | Alpha Tau Medical | $2.50 | 700% | Cantor Fitzgerald | Kristen Kluska | → $20 | Initiates | → Overweight | Get Alert |
04/08/2022 | DRTS | Buy Now | Alpha Tau Medical | $2.50 | 660% | Piper Sandler | Jason Bednar | → $19 | Initiates | → Overweight | Get Alert |
04/04/2022 | DRTS | Buy Now | Alpha Tau Medical | $2.50 | 740% | Citigroup | Neena Bitritto-Garg | → $21 | Initiates | → Buy | Get Alert |
The latest price target for Alpha Tau Medical (NASDAQ: DRTS) was reported by HC Wainwright & Co. on March 12, 2024. The analyst firm set a price target for $9.00 expecting DRTS to rise to within 12 months (a possible 246.15% upside). 12 analyst firms have reported ratings in the last year.
The latest analyst rating for Alpha Tau Medical (NASDAQ: DRTS) was provided by HC Wainwright & Co., and Alpha Tau Medical reiterated their buy rating.
There is no last upgrade for Alpha Tau Medical.
There is no last downgrade for Alpha Tau Medical.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Alpha Tau Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Alpha Tau Medical was filed on March 12, 2024 so you should expect the next rating to be made available sometime around March 12, 2025.
While ratings are subjective and will change, the latest Alpha Tau Medical (DRTS) rating was a reiterated with a price target of $0.00 to $9.00. The current price Alpha Tau Medical (DRTS) is trading at is $2.60, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.